WallStSmart

Bon Natural Life Ltd (BON)vsLinde plc Ordinary Shares (LIN)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Linde plc Ordinary Shares generates 192465% more annual revenue ($36.24B vs $18.82M). LIN leads profitability with a 19.3% profit margin vs -60.4%. LIN earns a higher WallStSmart Score of 54/100 (C-).

BON

Avoid

31

out of 100

Grade: F

Growth: 2.7Profit: 2.0Value: 5.0Quality: 6.5
Piotroski: 2/9Altman Z: 1.99

LIN

Buy

54

out of 100

Grade: C-

Growth: 4.0Profit: 8.0Value: 3.3Quality: 4.0
Piotroski: 3/9Altman Z: 1.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for BON.

LINSignificantly Overvalued (-61.7%)

Margin of Safety

-61.7%

Fair Value

$318.00

Current Price

$511.55

$193.55 premium

UndervaluedFair: $318.00Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

BON2 strengths · Avg: 9.5/10
Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.249/10

Conservative balance sheet, low leverage

LIN2 strengths · Avg: 9.0/10
Market CapQuality
$236.08B10/10

Mega-cap, among the largest globally

Operating MarginProfitability
28.0%8/10

Strong operational efficiency at 28.0%

Areas to Watch

BON4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.9%4/10

1.9% revenue growth

Altman Z-ScoreHealth
1.994/10

Grey zone — moderate risk

Market CapQuality
$9.31M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

LIN4 concerns · Avg: 3.3/10
PEG RatioValuation
2.004/10

Expensive relative to growth rate

P/E RatioValuation
34.1x4/10

Premium valuation, high expectations priced in

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

EPS GrowthGrowth
-10.5%2/10

Earnings declined 10.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : BON

The strongest argument for BON centers on Price/Book, Debt/Equity.

Bull Case : LIN

The strongest argument for LIN centers on Market Cap, Operating Margin. Profitability is solid with margins at 19.3% and operating margin at 28.0%.

Bear Case : BON

The primary concerns for BON are Revenue Growth, Altman Z-Score, Market Cap.

Bear Case : LIN

The primary concerns for LIN are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

BON profiles as a turnaround stock while LIN is a mature play — different risk/reward profiles.

LIN carries more volatility with a beta of 0.71 — expect wider price swings.

LIN is growing revenue faster at 9.2% — sustainability is the question.

LIN generates stronger free cash flow (833M), providing more financial flexibility.

Bottom Line

LIN scores higher overall (54/100 vs 31/100), backed by strong 19.3% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Bon Natural Life Ltd

BASIC MATERIALS · SPECIALTY CHEMICALS · China

Bon Natural Life Limited is dedicated to the research and development, manufacture and sale of functional active ingredients extracted from natural herbal plants. The company is headquartered in Cayman Islands.

Linde plc Ordinary Shares

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Linde plc is a multinational chemical company. It is the largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.

Visit Website →

Want to dig deeper into these stocks?